1 The effects of chronic treatment with the dihydropyridine, Bay K 8644, were studied on the ethanol withdrawal syndrome, in vivo and in vitro. 2 Addition of racemic Bay K 8644 to the drinking mixture, throughout the chronic ethanol treatment, decreased the behavioural excitability seen during ethanol withdrawal in vivo. 3 All the signs of hyperexcitability in field potentials in the isolated hippocampal slice, caused by ethanol withdrawal, were decreased by the chronic administration of Bay K 8644. 4 These effects resembled those previously reported for chronic administration of calcium channel antagonists; racemic Bay K 8644 has both calcium channel activating and antagonist properties. 5 Measurement of brain levels of Bay K 8644 at the end of the chronic treatment showed that the compound reached micromolar concentrations during the treatment, but none could be detected in the tissues at the time of the above measurements. 6 It is possible that the results might be explained by predominance of the calcium channel antagonist properties of this compound, owing to the high central concentrations achieved during the treatment. Tolerance to the calcium channel activating properties of Bay K 8644 may also have occurred during the chronic treatment.
Introduction
Ethanol has acute actions on many systems, but the basis of the dependence that develops on chronic treatment is not certain. There has been much interest recently in the actions of ethanol on calcium-mediated control mechanisms in neurones. Calcium spikes in cultured neurones were decreased by ethanol (Stokes & Harris, 1982) . Ethanol decreased the fast phase of depolarization-induced calcium flux into neurones and tolerance developed to this effect on chronic treatment (Harris & Hood, 1980; Friedman et al., 1980) . Chronic ethanol treatment has been found to increase the number of dihydropyridine-sensitive high affinity binding sites in the CNS . These sites are thought to correspond to voltage-sensitive calcium channels, of the highvoltage activated subtype. They do not appear to play a large part in normal neuronal activity, although effects have been reported in neurones under experimental conditions leading to prolonged depolarization (Docherty & Brown, 1986a; Louvel et al., 1986; Jones & Heinemann, 1987; Takahashi et al., 1989; Grover & Teyler, 1990) .
Dihydropyridine calcium channel antagonists were found to have a protective effect against the ethanol withdrawal syndrome in vivo; this effect was stereospecific (Littleton et al., 1990) . We have also found that the dihydropyridine calcium channel antagonist, PN 200-110, stereospecifically prevented all the measured signs of hyperexcitability in the isolated hippocampal slice caused by withdrawal from chronic ethanol treatment in vivo (Whittington & Little, 1991a) . The changes in the field potentials, caused by ethanol withdrawal, included decreases in thresholds for production of population spikes, following both orthodromic and antidromic stimulation, increases in paired pulse potentiation and shifts to the left of the input/output curves (Whittington & Little, 1990a; 1991a,b) . They followed different time courses during the withdrawal period, suggesting different origins of the forms of hyperexcitability.
Author for correspondence.
Adaptive responses to chronic ethanol administration can be modulated by concurrent chronic treatment with a dihydropyridine calcium channel antagonist. Nitrendipine, given concurrently with ethanol in chronic treatment, prevented the development of tolerance to ethanol (Wu et al., 1987;  Dolin & Little, 1989) . Nitrendipine, given chronically with ethanol, also prevented the ethanol withdrawal syndrome (Whittington et al., 1991) and decreased the electrophysiological manifestations of withdrawal described above (Whittington & Little, 1991b) . These effects were considered to be responses to the continued presence of nitrendipine, rather than acute actions, as the CNS concentrations at the time of testing were too low to produce acute effects in either the tolerance studies or on the withdrawal measurements (Dolin & Little, 1989; Whittington et al., 1991) . The increase in the number of dihydropyridine binding sites, measured after chronic ethanol administration, was also prevented, suggesting a possible causal relationship between the changes at these sites and development of ethanol tolerance and dependence (Dolin et al., 1988a; Dolin & Little, 1989) . Long-term administration of a dihydropyridine calcium channel antagonist causes down-regulation of the high affinity binding sites (Panza et al., 1985) . We have put forward the theory that the effects of concurrently administered calcium channel antagonists in preventing ethanol dependence were due to the prevention of the upregulation of voltage-sensitive calcium channels (Littleton & Little, 1989; Whittington et al., 1991; Little, 1991) .
The dihydropyridine, Bay K 8644, has been shown to increase the opening of voltage-sensitive calcium channels (Schramm et al., 1983; Brown et al., 1984; Nowycky et al., 1985) and this effect of Bay K 8644 has been shown to be the property of the (-)-isomer (Hof et al., 1985) . In 
The ethanol withdrawal syndrome
The ethanol withdrawal syndrome was measured by ratings of convulsive behaviour (Goldstein & Pal, 1971; Little et al., 1990 
Statistical analysis of withdrawal ratings
The ratings of the withdrawal syndrome, expressed as median and interquartile range, were compared by nonparametric analysis of variance, designed for repeat measurements on the same samples and multiple comparisons with controls (Meddis, 1984 The thresholds for the production of population spikes, and levels of paired pulse potentiation of these responses, were measured every 15 min. Measurements were made of the thresholds for eliciting single population spikes and multiple population spikes as described previously (Whittington & Little, 1990a) . Input/output curves were determined at 1, 3, 5, and 7 h from the preparation of tissues. These were made for the population spikes and for the slopes of the field e.p.s.ps (excitatory postsynaptic potentials). The field e.p.s.ps were recorded from the cell body area, so the measurements were made at some distance from the actual origin of the dendritic e.p.s.ps.
Certain precautions were taken to ensure that valid comparisons could be made between the field potentials from tissues from different treatment groups (Whittington & Little, 1990a) . The order of testing and the distribution of the various treatments between the two recording chambers were carefully balanced. The positions of the stimulating and recording electrodes were determined in every tissue by using the ends of the arc of granular cells in the dentate gyrus and the apex of the CA3 region above the fimbria as common reference points between slices.
The composition of the perfusion fluid was (mM): NaCI 124, KCl 3.25, NaH2PO4 1.25, NaHCO3 20.0, MgSO4 2.0, CaCl2 2.0, and D-glucose 10.0. The pH was 7.2 at 30°C. At the completion of every day's experiments the perfusion chamber was washed through with distilled water for at least 30min, and washed through every 5 days with sodium hydroxide followed by citric acid. (Figure 2 ). This effect lasted for 2h, then declined over the next 4h. The difference from control values was significant over the period 1 h to 6h from injection (P < 0.001).
Statistical analysis of electrophysiological results

Electrophysiological recordings
Thresholds for eliciting population spikes As shown previously (Whittington & Little, 1990a) , chronic ethanol treatment lowered the thresholds for eliciting both single and multiple population spikes in the CAI area. These effects were significant over the time period 2h to 7h from ethanol withdrawal (P < 0.001). Chronic administration of Bay K 8644 significantly decreased the effects of chronic ethanol on both these thresholds (Figures 3 and 4) . The difference between the thresholds after treatment with ethanol alone and ethanol plus Bay K 8644 was significant from 3h to 7h (P < 0.001). An example of the form of multiple spiking seen during ethanol withdrawal, and the absence of this form of spiking is shown in Figure 5 .
Paired pulse potentiation The paired pulse potentiation of the population spike was increased after ethanol treatment ( Figure 6 ), but, as we have demonstrated previously (Whittington & Little, 1990a; 1991a,b) , this change followed a different time course from that of the changes in thresholds, being maximal at 2 h from withdrawal, and returning to control values by between 3.5 h and 4 h. The chronic Bay K 8644 treatment considerably, and significantly, reduced the effects of chronic ethanol on paired pulse potentiation. The difference between the results after ethanol alone and after ethanol plus Bay K 8644 was significant (P < 0.001) when compared over the time period 1 h to 4 h from ethanol withdrawal.
Input/output curves The input/output curves for the population spike areas showed a shift to the left after chronic ethanol treatment, measured as a decrease in the minimum stimulus intensity required to evoke half-maximal population spikes (S50). A significant decrease in the gradients after chronic ethanol treatment was also seen between 3 h and 7h into withdrawal (see Table 1 ). These changes were significantly decreased by the addition of Bay K 8644 to the drinking mixture (P < 0.05). The input/output curves for the field e.p.s.p. slopes did not show any significant changes after the chronic ethanol alone, or ethanol and Bay K 8644 treatment schedules (P > 0.05, for comparison with control data) ( Table  1 ). An example of the input/output curves obtained is shown in Figure 7 , drawn from data obtained 7 h after ethanol withdrawal. 
Dihydropyridine binding
The data from the receptor binding studies ( (Table 2) .
Discussion
The addition of Bay K 8644 to the chronic ethanol treatment completely prevented the ethanol withdrawal syndrome in mice in vivo and significantly decreased the electrophysiological signs of withdrawal in the isolated hippocampal slices. These actions closely resembled the effects previously reported for chronic treatment with the calcium channel antagonist, nitrendipine (Whittington et al., 1991; Whittington & Little, 1991b) . Bay K 8644 is normally considered to increase calcium channel opening (Brown et al., 1984; Nowycky et al., 1985) , but it may have other actions (see below). In the present study, after removal of Bay K 8644 from the drinking fluid for the last 24h of ethanol intake, the central concentrations fell to levels below the detection of the assay, that is below about 150nm. This is lower than would have been required to cause behavioural changes by an acute action. We conclude, therefore, that the effects seen were due to the presence of Bay K 8644 in the CNS during the ethanol chronic treatment, rather than to any acute actions at the time of testing. The concentration of any residual Bay K 8644 in the hippocampal slices during recording would also have been lower than those required to produce acute effects on the withdrawal hyperexcitability (see below). A dose of 2mgkg-' was chosen to illustrate the acute effects, and this produced central concentrations of around 61uM at a time when the excitatory action was maximal. This action is lost at doses below about 1 mg kg-1 (our unpublished results and O'Neill & Bolger, 1988) . The central concentrations measured in the present study after the acute dosing are similar to those reported by O'Neill & Bolger (1988) , who found a level of approximately 2 gm in mouse brain 15 min after 2 mg kg-1 i.p.
When given acutely to control mice, racemic Bay K 8644 caused a pattern of behaviour that resembled in some respects that seen during ethanol withdrawal. The ratings of convulsive behaviour on handling were increased. Bolger et al. (1985) have reported that single doses of the racemate produced signs of hyperexcitability in naive mice. We found previously that a dose of 2mgkg-l of the racemate did not significantly affect the ethanol withdrawal syndrome when given acutely on withdrawal, but did prevent the protective action of the calcium channel antagonist, nimodipine (Littleton et al., 1990) . However this was not a simple interaction, as the withdrawal syndrome was increased by the combination of nimodipine plus Bay K 8644. We have also shown that the (-)-isomer of Bay K 8644 increased the ratings of convulsive behaviour during ethanol withdrawal (unpublished results Whittington et al., 1991) . (Whittington & Little, 1990b) . The brain concentrations of each of the isomers during the chronic treatment in the present study would have been in the same range as the concentration that increased (minus isomer) or decreased (plus isomer) the effects of ethanol withdrawal when added in vitro.
The demonstration of similar effects with a calcium channel activator and a calcium channel antagonist seem contradictory, but the results may have been due to the fact that racemic Bay K 8644 is not a pure calcium channel activator. It is well established that the effects of Bay K 8644 are stereospecific, the calcium channel activating properties of Bay K 8644 residing in the (-)-isomer, while the (+)-isomer is a calcium channel antagonist, both in vitro (Schramm et al., 1983; Hof et al., 1985; Franckowiak et al., 1985) and in vivo (O'Neill & Bolger, 1988) . In addition, in vitro studies have shown loss of effects and possible antagonist actions at high concentrations of Bay K 8644, as the dose-response curves in many studies showed a bell-shaped pattern. Concentrations over l0OnM of the (-)-isomer were found, by Franckowiak et al. (1985) , to have less effect on cardiac tissues than lower concentrations. Biphasic dose-response curves have been demonstrated for the racemate in cardiac preparations (Dube et al., 1985) . Hess et al. (1984) did not report biphasic effects on cardiac cells at concentrations of the racemate up to 10pM, but these authors mentioned that a 'partial antagonist' action was seen when strong depolarizations were applied. Few studies of the effects of Bay K 8644 on neuronal preparations have investigated a range of concentrations, but White & Bradford (1986) demonstrated biphasic effects of Bay K 8644 on the stimulation of calcium uptake by synaptosomes. The potentiating effect of Bay K 8644 was maximal at 1-10 nm and disappeared as the concentration was raised to 1-10 pm. The stimulation of inositol phospholipid hydrolysis by Bay K 8644 was half-maximal at 0.3 fM and declined at concentrations over 10pUM (Kendall & Nahorski, 1985) .
The effects of Bay K 8644 may also be influenced by the membrane potential. In patch-clamp studies on ventricular myocytes, the (-)-isomer and the racemate of Bay K 8644 have been shown to increase calcium currents evoked from negative, non-depolarizing, potentials, but to possess calcium channel antagonist properties on currents evoked from more positive holding potentials (Sanguinetti & Kass, 1984; Sanguinetti et al., 1986; Kass, 1987) . Brown et al. (1984) (Dolin et al., 1988b) . The central concentrations produced by these doses were 1 fM for the 1 mg kg -dose and 4.6 and 11.8/tM, respectively, for the two higher doses. In the present study, no overt behavioural changes were seen during the chronic treatment.
The central concentrations of Bay K 8644 during the chronic treatment were in the low micromolar range. Calcium channel antagonist actions have been reported at concentrations of the racemate from 500 nm to 5 pM in various tissues (see above), while the calcium channel activating effects have been seen at nanomolar concentrations, and a similar pattern was seen in the in vivo interactions with ethanol (Dolin et al., 1988b) . It is possible, therefore, that because the central concentrations during the chronic treatment were in this range, calcium channel antagonist actions were produced, rather than calcium channel activation. However, this does not provide a complete explanation, as the behavioural effects of single doses of the racemate, sufficient to produce these concentrations, are excitatory when the compound is given alone.
One possible explanation for the effects of the chronic treatment may be that tolerance to the excitatory effects may have occurred. O'Neill & Bolger (1988) demonstrated tolerance to the excitatory behavioural effects of racemic Bay K 8644 after four, once daily, injections of a dose that produced central concentrations of 2,igg'1. Although the incidence of convulsions was not decreased by this short course of repeated administration, their latency was increased and other signs of hyperexcitability were reduced. The brain concentrations in this study were similar to those in the present work; both were in the low micromolar range. The present authors are unaware of any reports of tolerance to the calcium channel antagonist effects of the (+)-isomer of Bay K 8644. If such tolerance occcurred to the calcium channel activating actions of the (-)-isomer of Bay K 8644 during the more prolonged chronic treatment in the present study, the resultant action on the CNS would have been that of the (+), calcium channel antagonist, isomer.
One possible explanation for the results in this study, therefore, is that the protective action of chronic administration of racemic Bay K 8644 on the ethanol withdrawal syndrome in vivo and in vitro, may have been due to a combination of the calcium channel antagonist properties of this compound, caused by the high concentrations in the CNS, plus tolerance to the calcium channel activating actions. Studies using lower doses of Bay K 8644, and if possible, the stereoisomers, are needed to investigate these theories. It was apparent throughout the studies that the patterns of results seen in the behavioural, receptor binding and electrophysiological experiments all followed the same pattern, the only exception being the effects of the Bay K 8644 on paired pulse potentiation in the hippocampal slices.
